首页> 美国卫生研究院文献>ACS AuthorChoice >Comprehensive Vibrational Spectroscopic Investigationof transtranstrans-Pt(N3)2(OH)2(py)2 a Pt(IV) Diazido Anticancer ProdrugCandidate
【2h】

Comprehensive Vibrational Spectroscopic Investigationof transtranstrans-Pt(N3)2(OH)2(py)2 a Pt(IV) Diazido Anticancer ProdrugCandidate

机译:振动光谱综合研究反式反式反式-Pt(N3)2(OH)2(py)2一种Pt(IV)重氮基抗癌前药候选人

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report a detailed study of a promising photoactivatable metal-based anticancer prodrug candidate, trans,trans,trans-[Pt(N3)2(OH)2(py)2] (>C1; py = pyridine), using vibrational spectroscopic techniques. Attenuated total reflection Fourier transform infrared (ATR-FTIR), Raman, and synchrotron radiation far-IR (SR-FIR) spectroscopies were applied to obtain highly resolved ligand and Pt-ligand vibrations for >C1 and its precursors (trans-[Pt(N3)2(py)2] (>C2) and trans-[PtCl2(py)2] (>C3)). Distinct IR- and Raman-active vibrational modes were assigned with the aid of density functional theory calculations, and trends in the frequency shifts as a function of changing Pt coordination environment were determined and detailed for the first time. The data provide the ligand and Pt-ligand (azide, hydroxide, pyridine) vibrational signatures for >C1 in the mid- and far-IR region, which will provide a basis for the better understanding of the interaction of >C1 with biomolecules.
机译:我们报告了一个有前途的光活化金属基抗癌前药候选物,反式,反式,反式-[Pt(N3)2(OH)2(py)2](> C1 ; py =吡啶),使用振动光谱技术。使用衰减全反射傅立叶变换红外(ATR-FTIR),拉曼光谱和同步辐射远红外(SR-FIR)光谱仪来获得> C1 及其前体的高度分辨的配体和Pt-配体振动(反-[Pt(N3)2(py)2](> C2 )和反-[PtCl2(py)2](> C3 ))。借助密度泛函理论计算,确定了不同的IR和拉曼振动模式,并首次确定并详细说明了频移随Pt配位环境变化的趋势。这些数据提供了中红外和远红外区域> C1 的配体和Pt-配体(叠氮化物,氢氧化物,吡啶)的振动特征,这将为更好地理解C1相互作用提供基础。 > C1 与生物分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号